Long-Term Outcome of Patients With a Hematologic Malignancy and Multiple Organ Failure Admitted at the Intensive Care

Autor: Vries, V.A. de, Muller, M.C.A., Arbous, M.S., Biemond, B.J., Blijlevens, N.M.A., Kusadasi, N., Span, L.R.F., Vlaar, A.P.J., Westerloo, D.J. van, Kluin-Nelemans, H.C., Bergh, W.M. van den, Tuinman, P.R., Spoelstra, A., Marijt, E., Blijlevens, N., Hilkens, M., Epker, J., Broers, A., Choi, G., Demandt, A., Mook, W. van, HEMA-ICU Study Grp

Publikováno v: Critical Care Medicine
Critical Care Medicine, 47(2), E120-E128. LIPPINCOTT WILLIAMS & WILKINS
Critical Care Medicine, 47, 2, pp. E120-E128
de Vries, V A, Mueller, M C A, Arbous, M S, Biemond, B J, Blijlevens, N M A, Kusadasi, N, Span, L R F, Vlaar, A P J, van Westerloo, D J, Kluin-Nelemans, H C, van den Bergh, W M, Tuinman, P R, Spoelstra, A, Marijt, E, Blijlevens, N, Hilkens, M, Epker, J, Broers, A, Choi, G, Demandt, A & van Mook, W 2019, ' Long-Term Outcome of Patients With a Hematologic Malignancy and Multiple Organ Failure Admitted at the Intensive Care ', Critical Care Medicine, vol. 47, no. 2, pp. E120-E128 . https://doi.org/10.1097/CCM.0000000000003526
Critical Care Medicine, 47, E120-E128
Critical care medicine, 47(2), e120-e128. Lippincott Williams and Wilkins
Critical Care Medicine, 47(2), E120-E128
Critical Care Medicine, 47(2), E120-E128. Lippincott Williams & Wilkins
Critical Care Medicine, 47(2), E120-E128. Lippincott Williams and Wilkins

Objectives: Historically, patients with a hematologic malignancy have one of the highest mortality rates among cancer patients admitted to the ICU. Therefore, physicians are often reluctant to admit these patients to the ICU. The aim of our study was

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4392eed5ee15bec87be3da4edc981b5d
http://europepmc.org/articles/PMC6336487